RIMONDI, Erika
 Distribuzione geografica
Continente #
NA - Nord America 3.245
EU - Europa 1.478
AS - Asia 1.173
SA - Sud America 132
AF - Africa 48
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.079
Nazione #
US - Stati Uniti d'America 3.208
PL - Polonia 512
SG - Singapore 423
CN - Cina 303
SE - Svezia 216
UA - Ucraina 160
HK - Hong Kong 120
IT - Italia 115
VN - Vietnam 114
BR - Brasile 104
GB - Regno Unito 81
FR - Francia 80
FI - Finlandia 73
KR - Corea 61
DE - Germania 52
TR - Turchia 52
RU - Federazione Russa 51
BG - Bulgaria 34
IE - Irlanda 32
IN - India 32
MA - Marocco 26
CA - Canada 23
CH - Svizzera 21
NL - Olanda 17
BE - Belgio 13
IQ - Iraq 11
BD - Bangladesh 10
AR - Argentina 9
JP - Giappone 9
MX - Messico 9
MY - Malesia 8
CL - Cile 5
LT - Lituania 5
ZA - Sudafrica 5
CO - Colombia 4
ES - Italia 4
ID - Indonesia 4
DZ - Algeria 3
KE - Kenya 3
SA - Arabia Saudita 3
SN - Senegal 3
VE - Venezuela 3
AL - Albania 2
AM - Armenia 2
AT - Austria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
IR - Iran 2
JO - Giordania 2
LV - Lettonia 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
PY - Paraguay 2
TN - Tunisia 2
UZ - Uzbekistan 2
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MM - Myanmar 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SL - Sierra Leone 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.079
Città #
Warsaw 479
Woodbridge 361
Fairfield 321
Ann Arbor 305
Ashburn 292
Singapore 269
Houston 234
Chandler 225
Wilmington 156
Jacksonville 152
Hong Kong 120
Seattle 115
San Jose 114
Cambridge 93
Beijing 69
Dallas 67
Boardman 62
Hefei 62
Seoul 61
Princeton 58
Izmir 46
Chicago 38
Ho Chi Minh City 38
Lauterbourg 36
Sofia 34
Columbus 33
Dearborn 32
Dublin 32
Trieste 32
Los Angeles 29
Zgierz 29
Hanoi 27
Buffalo 26
London 26
Casablanca 23
Helsinki 21
Moscow 21
Santa Clara 20
Frankfurt am Main 18
San Diego 18
Council Bluffs 17
Bern 16
São Paulo 16
The Dalles 14
Brussels 13
Düsseldorf 12
New York 12
Tokyo 9
Dong Ket 8
Falls Church 8
Nanjing 8
Atlanta 7
Chennai 7
Guangzhou 7
Milan 7
Orem 7
Ottawa 6
Rio de Janeiro 6
Stockholm 6
Tianjin 6
Auburn Hills 5
Denver 5
Des Moines 5
Ferrara 5
Haiphong 5
Jinan 5
Johannesburg 5
Kunming 5
Mumbai 5
Phoenix 5
Redondo Beach 5
Toronto 5
Nanchang 4
Nuremberg 4
Shanghai 4
Zurich 4
Amsterdam 3
Baghdad 3
Belo Horizonte 3
Bogotá 3
Boston 3
Chengdu 3
Dakar 3
Dhaka 3
Fortaleza 3
Fremont 3
Hangzhou 3
Hưng Yên 3
Kuala Lumpur 3
Montreal 3
Nairobi 3
North Bergen 3
Norwalk 3
Portsmouth 3
San Francisco 3
Santiago 3
Shenzhen 3
Wroclaw 3
Abidjan 2
Amman 2
Totale 4.532
Nome #
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 385
The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway 356
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 303
C-Reactive protein downregulates TRAIL expression in human peripheral monocytes via an Egr-1-dependent pathway. 266
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 243
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors. 230
TNF-related apoptosis inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. 222
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL). 220
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 220
MDM2 antagonist nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts via a p53-dependent pathway. 211
Activation of PKC-e counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 210
Inhibitory effect of natural anti-inflammatory compounds on cytokines released by chronic venous disease patient-derived endothelial cells. 207
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. 200
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 200
TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end points:induction of apoptosis and PGE2 release. 195
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. 194
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. 190
Receptor activator of nuclear factor kappa B ligand(RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts. 187
GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients. 185
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 184
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1. 180
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 178
Human colostrum and breast milk contain high levels of TNF-related apoptosis-inducing ligand (TRAIL). 175
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 164
Levels of TNF-related apoptosis-inducing ligand (TRAIL) show a long-term stability in the breast milk of mothers of preterm infants. 155
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 147
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. 136
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 130
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 107
Role of vitamin D in the pathogenesis of atheromatosis 106
Mevalonate kinase deficiency and squalene synthase inhibitor (TAK-475): The balance to extinguish the inflammation 85
Totale 6.171
Categoria #
all - tutte 16.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021121 0 0 0 0 0 0 0 0 0 53 15 53
2021/2022378 24 19 20 50 8 30 23 11 46 32 23 92
2022/2023578 39 83 54 96 48 107 2 49 70 5 21 4
2023/2024256 26 28 10 18 30 17 43 46 1 2 13 22
2024/2025605 13 32 53 65 46 61 58 26 63 74 68 46
2025/20261.518 166 83 153 164 171 141 197 56 207 180 0 0
Totale 6.171